课题基金 / 基金详情

Discovery of a novel gastrointestinal signaling mechanism in the ability of metformin to lower glucose production and blood glucose levels during diabetes

Discovery of a novel gastrointestinal signaling mechanism in the ability of metformin to lower glucose production and blood glucose levels during diabetes
发现二甲双胍能够降低糖尿病期间葡萄糖产生和血糖水平的新型胃肠信号传导机制
批准号：
302099
负责人：
Duca Frank A
金额：
$3.28万
依托单位：
University Health Network (Toronto)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-11-01 至 2015-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=302099&lang=en
关键词：
Anti-Diabetic Agents Diabetes Endocrinology Gastroenterology Gastrointestinal Tract Metabolism Metformin Nutrient-Sensing Nutrition Obesity

项目摘要

项目成果

Duca Frank A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Diabetes affects a staggering 347 million people worldwide, and in Canada alone, more than 9 million individuals are diabetic or pre-diabetic. As environmental factors continue to shift towards an obesogenic lifestyle, both obesity and diabetes rates will
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of metformin action in the upper small intestine
  • 批准号：
    339164
  • 项目类别：
    Fellowship Programs
  • 资助金额：
    $3.28万
  • 财政年份：
    2015
  • 负责人：
    Duca Frank A
  • 依托单位：
    University Health Network (Toronto)
Discovery of novel molecular and pharmacological mechanisms in the ability of metformin to lower glucose production and blood glucose levels during diabetes
  • 批准号：
    297266
  • 项目类别：
    Fellowship Programs
  • 资助金额：
    $10.2万
  • 财政年份：
    2013
  • 负责人：
    Duca Frank A
  • 依托单位：
    University Health Network (Toronto)
海外基金